| 注册
首页|期刊导航|中国药理学通报|线粒体与心肌缺血/再灌注损伤

线粒体与心肌缺血/再灌注损伤

李雪丽 刘建勋

中国药理学通报2012,Vol.28Issue(12):1633-1636,4.
中国药理学通报2012,Vol.28Issue(12):1633-1636,4.DOI:10.3969/j.issn.1001-1978.2012.12.002

线粒体与心肌缺血/再灌注损伤

Mitochondria and myocardial ischaemia/reperfusion injury

李雪丽 1刘建勋2

作者信息

  • 1. 中国中医科学院西苑医院实验研究中心,北京,100091
  • 2. 北京中医药大学,北京,100029
  • 折叠

摘要

Abstract

Myocardial ischaemia/reperfusion ( I/R ) cause a wide array of alterations of mitochondrial homeostasis, such as loss of ATP synthesis, increase of ROS generation, Ca2+ overload, membrane permeabilization, fragmentation of mitochondria and so on. The series of events are linked together and involved in the process of I/R injury, play critical roles in cardiomyocytes injury. This paper reviews the advancement of mitochondrial pathological changes during I/R and mitochondrial protective pathway of I/R injury, in order to understand the important mechanisms of I/R injury associated with mitochondria and provide references for cardiovascular disease treatment strategies and drug development based on mitochondrial protection.

关键词

缺血/再灌注/线粒体膜通透性/线粒体形态/ROS/Ca2+/mPTP/mKATP

Key words

ischaemia/reperfusion/ mitochondrial permeability/mitochondrial morphology/ ROS/ Ca + / mPTP/ mKATP

分类

医药卫生

引用本文复制引用

李雪丽,刘建勋..线粒体与心肌缺血/再灌注损伤[J].中国药理学通报,2012,28(12):1633-1636,4.

基金项目

国家自然科学基金重点项目(No 30830118) (No 30830118)

重大新药创制综合性中药新药研究开发技术平台(No 2009ZX09301-005-007) (No 2009ZX09301-005-007)

中国药理学通报

OA北大核心CSCDCSTPCD

1001-1978

访问量0
|
下载量0
段落导航相关论文